By
Drug Target Review2025-01-24T08:00:01
UVA researchers found that continuous glucose monitor data can predict nerve, eye, and kidney damage in type 1 diabetes.
Already a member? Sign in
By highlighting cutting-edge research and its practical applications, Drug Target Review enables readers to make decisions that accelerate innovation, translate discoveries into therapies, and create tangible benefits for patients worldwide.
By becoming a member you join a connected and collaborative community driving the industry forward. Member benefits include:
2026-06-22T13:04:00Z
2026-06-22T07:00:00Z
2026-06-04T07:05:00
Author Graham Craig
2024-01-19T07:40:55
Sponsored by Euretos
2023-03-23T14:46:21
Sponsored by Bio-Techne
2023-09-27T13:56:39
Sponsored by Euretos
2023-05-31T15:16:10
Sponsored by Bio-Techne
2023-01-19T15:38:17
Sponsored by Cell Signaling Technology
Site powered by Webvision Cloud